Skip to main content
. Author manuscript; available in PMC: 2011 Mar 18.
Published in final edited form as: Cancer Biol Ther. 2008 Oct 9;7(10):1607–1618. doi: 10.4161/cbt.7.10.6584

Table 2.

Transcripts with at least three fold higher levels in cells treated with SAHA alone vs. untreated cells

(A) Transcripts changed by at least 3 fold after treatment with SAHA (alphabetical order): SKRC06
Gene Fold change SAHA/con p value Description
Akap2 3.127 0.0123 A KINASE ANCHOR PROTEIN 2
Atf5 0.31 0.00634 ACTIVATING TRANSCRIPTION FACTOR 5
Adcy7 0.312 0.00338 ADENYLATE CYCLASE 7
Akrc1c3 3.996 0.00391 ALDO-KETO REDUCTASE FAMILY 1, MEMBER C3
Ccl20 10.39 5.2e-5 CHEMOKINE LIGAND 20
Cyp1b1 0.328 0.00971 CYTOCHROME-450, FAMILY 1, SUBFAMILY B, POLYPEPTIDE 1
Ef1a 4.144 0.000342 EUKARYOTIC TRANSLATION ELONGATION FACTOR1, α 2
Igsf4 3.076 0.00873 IMMUNOGLOBULIN SUPERFAMILY, MEMBER 4
Il1 α 5.224 4.59e-6 INTERLEUKIN1, α
Mbnl3 0.273 0.00851 MUSCLEBLIND-LIKE 3 (DROSOPHILA)
Phf11 0.287 5.87e-5 PHD FINGER PROTEIN 11
Plekhc1 3.922 0.00162 PLECKSTRIN HOMOLOGY DOMAIN CONTAINING, ,FAMILY C
Ryr1 0.191 0.0457 RYANODINE RECEPTOR 1
Serpinf1 0.294 0.000996 SERPIN PEPTIDASE INHIBITOR, CLADE F
Slc1a1 3.518 0.00176 SOLUTE CARRIER FAMILY 1
Srpx 7.497 9.12e-5 SUSHI-REPEAT-CONTAINING PROTEIN, X-LINKED
Trim22 0.264 0.00504 TRIPARTITE MOTIF CONTAINING 22
At3 3.004 0.00259 TUBULIN, α 3
Znf518 0.33 0.028 ZINC FINGER PROTEIN 518
(B) Transcripts changed by at least 3 fold after treatment with SAHA: SKRC39
Gene Fold change SAHA/con p value Description
ube2l6 0.211 0.0411 UBIQUITIN-CONJUGATING ENZYME E2L 6
ugt 0.278 0.0381 UDP GLUCORONOSYL 1 FAMILY, POLYPEPTIDE A10
kcns3 0.139 0.0374 POTASSIUM VOLTAGE-GATED CHANNEL
ugt1a8 0.323 0.0282 UDP GLUCORONYLTRANSFERASE 1, FAMILY
hpse 0.333 0.0243 HEPARANASE
rabac1 0.313 0.0217 RAB ACCEPTOR 1 (PRENYLATED)
sc[e[1 0.170 0.0191 SERINE CARBOXYPEPTIDASE
stom 0.289 0.0119 STOMATIN
eno2 0.174 0.0114 ENOLASE 2
fgf18 3.752 0.0112 FIBROBLAST GROWTH FACTOR 18
nef1 0.134 0.0112 NEUROFILAMENT, LIGHT POLYPEPTIDE 68KDA
epas1 0.2 0.0112 ENDOTHELIAL PAS DOMAIN PROTEIN 1
gucy1b3 0.317 0.0112 GUANYLATE CYCLASE, SOLUBLE, β 3
nedd9 0.307 0.0112 NEURAL PRECURSOR CELL EXPRESSED
gm2a 0.291 0.0112 GM2 GANGLIOSIDE ACTIVATOR
adrb2 0.191 0.00901 ADRENERGIC, β 2, RECEPTOR, SURFACE
itpnc1 0.226 0.00901 PHOPHATIDLINOSITOL TRANSFER PROTEIN, CYTOPLASMIC
akr1c3 0.32 0.00901 ALDO-KETO REDUCTASE FAMILY 1, MEMBER C3
at3 0.038 0.00721 TUBULIN, α 3
gsn 0.148 0.00632 GELSOLIN (AMYLOIDOSIS, FINNISH TYPE)
procr 0.194 0.00439 PROTEIN RECEPTOR, ENDOTHELIAL
c14orf78 0.299 0.00412 CHROMOSOME 14 OPEN READING FRAME 78
lmcd1 0.22 0.00412 LIM AND CYSTEINE-RICH DOMAINS 1
man1a1 0.264 0.00368 MANNOSIDASE, α, CLASS 1A, MEMBER 1
ccl20 0.123 0.000231 CHEMOKINE (C-C MOTIF) LIGAND 20

(A) Genes with three sfold or greater changes in mRNA levels in SKRC06 are listed in alphabetical order. The fold-change, p value and gene description are shown. (B) Results for SKRC39; genes are listed by decreasing p value. The greatest fold change for a gene with increased mRNA levels after SAHA addition was fgf18.